Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
diana.bellavia@uniroma1.it
Diana Bellavia
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA MOLECOLARE
E-mail:
diana.bellavia@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Loss of ATP2C1 function promotes trafficking and degradation of NOTCH1: Implications for Hailey-Hailey disease
EXPERIMENTAL DERMATOLOGY
2023
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance
FRONTIERS IN ONCOLOGY
2022
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL
CANCERS
2022
When viruses cross developmental pathways
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2021
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy
CANCERS
2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
ONCOGENESIS
2020
A dynamic role of mastermind-like 1: a journey through the main (path)ways between development and cancer
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2020
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer
CANCERS
2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells
STEM CELLS INTERNATIONAL
2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
FRONTIERS IN ONCOLOGY
2019
Notch/CXCR4 partnership in acute lymphoblastic leukemia progression
JOURNAL OF IMMUNOLOGY RESEARCH
2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype
JOURNAL OF ONCOLOGY
2019
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP
NATURE COMMUNICATIONS
2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer
FRONTIERS IN GENETICS
2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance
CANCER RESEARCH
2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression
THE JOURNAL OF BIOLOGICAL CHEMISTRY
2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response
The Biennial Congress of the Italian Association of cell biology and differentiation
2019
Notch/{CXCR}4 Partnership in Acute Lymphoblastic Leukemia Progression
JOURNAL OF IMMUNOLOGY RESEARCH
2019
Notch signaling as a therapeutic target for acute lymphoblastic leukemia
EXPERT OPINION ON THERAPEUTIC TARGETS
2018
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.
Atti del ABCD - PPh.D. meeting
2018
1
2
seguente ›
ultima »
Progetti di Ricerca
Jagged1, a novel non-canonical player in pancreatic cancer. Identification of novel target drugs
Jagged1 plays a key role in sustaining colon cancer (CRC) progression in a Notch-independent manner
Laboratori di ricerca
LABORATORIO BIOCHIMICO BIOLOGICO LIV BIOSICUREZZA 1 408
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma